Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aster DM Quality CareNSE:ASTERDM +0.96%78 Debt-to-EBITDA is 2.13 as of Mar. 2026, which is 33% below its 10-year median of 3.19. GuruFocus rates NSE:ASTERDM with a GF Score™ of 78/100 and a GF Value™ of ₹709.05 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Aster DM Quality Care ranks worse than 51.36% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Aster DM Quality Care's Debt-to-EBITDA or its related term are showing as below:
NSE:ASTERDM'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.02 Med: 3.19 Max: 5.37
Current: 2.32
During the past 12 years, the highest Debt-to-EBITDA Ratio of Aster DM Quality Care was 5.37. The lowest was 1.02. And the median was 3.19.
NSE:ASTERDM's Debt-to-EBITDA is ranked worse than 51.36% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.22
vs NSE:ASTERDM: 2.32
Aster DM Quality Care (NSE:ASTERDM) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Aster DM Quality Care Debt-to-EBITDA Related Terms
Aster DM Quality Care Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Aster DM Quality Care's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ASTERDM vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Aster DM Quality Care's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aster DM Quality Care Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aster DM Quality Care's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Aster DM Quality Care's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Aster DM Quality Care (NSE:ASTERDM) has a Debt-to-EBITDA of 2.13 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Aster DM Quality Care. This is 33% below median its historical median of 3.19. Over the past decade, Aster DM Quality Care's Debt-to-EBITDA has ranged from 1.02 to 5.37. According to the industry distribution chart, Aster DM Quality Care ranks #245 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 51.4%.
Is Aster DM Quality Care's Debt-to-EBITDA too high?
Aster DM Quality Care's current Debt-to-EBITDA of 2.13 is 33% below median its 10-year median of 3.19. Over the past 10 years, this metric has ranged from a low of 1.02 to a high of 5.37. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.22. Aster DM Quality Care's value of 2.13 is 4.1% below this industry median. Based on the distribution chart, Aster DM Quality Care ranks #245 out of 477 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Aster DM Quality Care has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aster DM Quality Care's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aster DM Quality Care ranks #245 out of 477 companies for Debt-to-EBITDA. This places Aster DM Quality Care in the lower half of its industry. The industry median Debt-to-EBITDA is 2.22. Aster DM Quality Care's value of 2.13 is 4.1% below this benchmark. Historically, Aster DM Quality Care's own Debt-to-EBITDA has ranged from 1.02 to 5.37 over the past decade. While the company's 10-year median is 3.19 vs. the industry median of 2.22, Aster DM Quality Care has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aster DM Quality Care's current Debt-to-EBITDA of 2.13 is 4.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Aster DM Quality Care. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aster DM Quality Care's current Debt-to-EBITDA is 2.13, which is 33% below median its own 10-year median of 3.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aster DM Quality Care stock overvalued right now?
Based on GuruFocus' analysis, Aster DM Quality Care (NSE:ASTERDM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹709.05, compared to a current price of ₹819.90 — trading 15.6% above its estimated fair value. The current Debt-to-EBITDA is 2.13, which is 33% below median its 10-year median of 3.19 and 4.1% below the Healthcare Providers & Services industry median of 2.22. Aster DM Quality Care's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Aster DM Quality Care (NSE:ASTERDM), the current Debt-to-EBITDA is 2.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?
Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued.
The current stock price of ₹819.90 is trading 15.6% above its estimated GF Value™ of ₹709.05.
GuruFocus considers Aster DM Quality Care to be Modestly Overvalued.
Key valuation signals for NSE:ASTERDM:
Debt-to-EBITDA: 2.13 (33% below median its 10-year median of 3.19)
GF Value™: ₹709.05 vs. price of ₹819.90 (15.6% above fair value)
Industry Position: 4.1% below the Healthcare Providers & Services median (#245 of 477)
No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
78GF Score
Get the complete analysis for NSE:ASTERDM
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTERDM has been successfully added to your 
